BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20251014T224210EDT-9923UjvHKm@132.216.98.100 DTSTAMP:20251015T024210Z DESCRIPTION:Le Centre des politiques en propriété intellectuelle le profess eur Jacob S. Sherkow\, New York Law School\, qui parlera de licences de br evets dans le milieu universitaire à l'ère de l'outil de génie génétique C RISPR-Cas9.\n\nRésumé\n\n[En anglais seulement] CRISPR is a revolutionary advance in biotechnology: it allows molecular biologists to edit cells’ DN A with ease and precision unimaginable even a decade ago. The technology i s also the subject of contentious patent dispute between several universit ies\, and governed by a maze of licensing agreements among research instit utions\, nonprofits\, biotech startups\, and large pharmaceutical develope rs.\n\nPatents in the CRISPR space illuminate numerous problems—and advant ages—of university-based intellectual property for groundbreaking technolo gies. The CRISPR patents herald the beginning of skepticism over interinst itutional collaboration\, especially for lucrative “translational” technol ogies. And they have encouraged universities—otherwise committed to licens ing their patents widely—to invest in for-profit surrogate companies to na rrowly manage their license agreements for them. At the same time\, CRISPR patents have allowed publicly minded research institutions to retain cont rol over the technology to essentially prevent some of the technology’s gr eatest potential abuses: runaway genetic modifications in the wild\, also known as “gene drives”\; seed-saving restrictions for agriculture\; and ge rm-line human engineering.\n\nUsing four short papers as guides\, this tal k will present an overview of these issues and discuss their application t o future applications of CRISPR and other significant university-developed technology.\n\nSpeaker\n\n[En anglais seulement] Jacob S. Sherkow is an A ssociate Professor of Law and affiliated faculty at the Innovation Center for Law and Technology at New York Law School\, where he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments\, especially in the biosciences\, affect patent la w and litigation. Prof. Sherkow is the author of over two dozen articles o n these and related topics in both traditional law reviews and scientific journals\, including the Yale Law Journal\, the Stanford Law Review\, Scie nce\, and Nature. He has been a frequent commentator on patent matters in popular outlets such as the Wall Street Journal\, The New York Times\, the Los Angeles Times\, and NPR.\n\nProf. Sherkow also currently serves as a community representative on the New York Genome Center’s Institutional Bio safety Committee\, and has advised a committee of France’s National Assemb ly on issues concerning the patenting of biotechnological research tools. Previously\, Prof. Sherkow was a Fellow in the Center for Law and the Bios ciences at Stanford Law School and a patent litigator at Gibson\, Dunn & C rutcher in New York. He was also a law clerk in the U.S. District Court fo r the Eastern District of New York.\n \n Prof. Sherkow graduated cum laude f rom the University of Michigan Law School\, where he was an editor of the Michigan Law Review and was the recipient of the Fred L. Leckie and James N. Adler Scholarships. He also holds an M.A. in biotechnology from Columbi a University and a B.Sc. from 9I\, where he majored in mole cular biology and English literature. In addition to his legal training\, Prof. Sherkow has several years of experience as a research scientist in m olecular biology\, is a certified Editor in the Life Sciences (BELS)\, and is an avid squash player.\n DTSTART:20170324T170000Z DTEND:20170324T183000Z LOCATION:NCDH 316\, Chancellor Day Hall\, CA\, QC\, Montreal\, H3A 1W9\, 36 44 rue Peel SUMMARY:University Patent Licenses in the CRISPR Era URL:/law/fr/channels/event/university-patent-licenses- crispr-era-266449 END:VEVENT END:VCALENDAR